Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, researchers aren’t giving up yet.

Artificial intelligence is moving from the lab into the clinic, and one of its most provocative promises is that it might ...

Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) ...

Dementia is common, but there are things you can do to reduce your risk or slow the progression of the disease.

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...